Cellular membrane cholesterol

Cellular membrane cholesterol serves as the primary molecular target for the saponin adjuvant QS-21, a triterpene glycoside extracted from the Quillaja saponaria tree. QS-21 interacts with cholesterol to form pores or induce endocytosis, leading to the destabilization of lysosomal membranes within antigen-presenting cells (PubMed: 21460038). This process triggers the release of cathepsin B into the cytosol, which subsequently activates the NLRP3 inflammasome, resulting in the production of pro-inflammatory cytokines such as IL-1beta and IL-18 (PubMed: 26324774). These events are essential for the potentiation of both antibody-mediated and cell-mediated immune responses, particularly Th1 and CD8+ T-cell activity (PubMed: 28245138). Due to its ability to cause hemolysis by disrupting red blood cell membranes, QS-21 is typically formulated within cholesterol-containing liposomes, such as in the AS01 adjuvant system, to neutralize its lytic activity while preserving its immunostimulatory properties (PubMed: 30104604). This target-adjuvant interaction is a cornerstone of modern vaccine technology, enabling high efficacy in populations with waning immunity, such as the elderly.

Other names

Membrane cholesterolPlasma membrane sterolsQS-21 targetCellular membranes via QS-21 saponin

QS-21 binds to membrane cholesterol, inducing lysosomal destabilization and NLRP3 inflammasome activation, which promotes Th1 and CD8+ T-cell immune responses (PubMed: 26324774, 30104604).